Abstract Purpose: To assess patient skin and eye lens doses in interventional neuroradiology and to assess both stochastic and deterministic radiation risks. Methods: Kermaarea product (P KA ) was recorded and skin doses measured using thermoluminescence dosimeters. Estimated dose at interventional reference point (IRP) was compared with measured absorbed doses. Results: The average and maximum fluoroscopy times were 32 and 189 min for coiling and 40 and 144 min for embolisation. The average and maximum P KA for coiling were 121 and 436 Gy cm 2 , respectively, and 189 and 677 Gy cm 2 for embolisation. The average and maximum values of the measured maximum absorbed skin doses were 0.72 and 3.0 Sv, respectively, for coiling and 0.79 and 2.1 Sv for embolisation. Two out of the 52 patients received skin doses in excess of 2 Sv. The average and maximum doses to the eye lens (left eye) were 51 and 515 mSv (coiling) and 71 and 289 mSv (embolisation). Conclusion: The ratio between the measured dose and the dose at the IRP was 0.44±0.18 mSv/ mGy indicating that the dose displayed by the x-ray unit overestimates the maximum skin dose but is still a valuable indication of the dose. The risk of inducing skin erythema and lens cataract during our hospital procedures is therefore small.
Introduction
Acute radiation injuries after radiological interventional procedures have been reported [1, 2] . It is therefore necessary to assess patient doses regularly, to identify patients at risk and to have proper protocols to minimise local skin doses and skin erythema as a result of these sometimes lengthy procedures. Operators of interventional radiology should, however, be aware of the potential risk of skin injury following such procedures, particularly for patients with collagen vascular disease, diabetes or previous skin exposure [3] . If proper quality assurance programs including patient dose monitoring, periodic equipment testing, procedure evaluation and training of staff, are established, the risk of skin injuries in interventional cardiology is very low [4] . The DIMOND and SENTINEL European research projects [5, 6] have contributed to the efficacy, safety and good practice of interventional radiology particularly for interventional cardiology, the most common interventional procedure.
Assessing local skin or eye lens doses and particularly their maximum values is difficult as different anatomical areas are exposed and many projections used. In addition, the x-ray beam size, fluence and radiation quality and finally the distances between the skin and the x-ray tube and image receptor vary both during the procedure and from patient to patient. Kosunen et al. [7] reviewed methods to estimate patient doses in interventional radiology and gave guidance on the accuracy one can expect using different dosimeters. Different dosimeters' photon energy and dose dependences and their clinical usefulness were characterised by Van Dam et al. [8] .
Estimating maximum dose is facilitated if the dosimeter displays the skin dose in real time, gives information about the position of the maximum dose and if the dosimeters do not interfere with the examination. Current x-ray imaging systems do not fully comply with these criteria. Fluoroscopy time is always available but is a very poor indicator of maximum skin dose. Balter and Moses [9] state that major interventional procedures using an imaging system equipped only with a fluoroscopic timer are not recommended. Most modern imaging systems for interventional radiology are, however, equipped with a kerma-area product (P KA ) meter. The air kerma-area product is the integral of the air kerma over the area of the x-ray beam in a plane perpendicular to the beam axis and is denoted P KA by the International Commission on Radiation Units and Measurements (ICRU) [10] and the International Atomic Energy Agency (IAEA) [11] . It is the same quantity as that sometimes denoted KAP. As P KA is nowadays readily available, one approach to assessing local skin dose is to measure P KA and correlate its value to the maximum skin dose. Chida et al. [12] found a strong correlation between P KA and maximum skin dose in percutaneous coronary interventions (PCI). This is not always the case [13] since the same P KA but different local skin dose can be obtained using a small intense beam or a larger less intense one. When as in some diagnostic procedures, for example in coronary angiography, image projections are known with reasonable accuracy in advance, P KA has been suggested as an appropriate measure [14] particularly for stochastic radiation effects. But is has also been suggested for use in interventional cardiology [15] . Others [16] [17] [18] have also suggested using P KA as an indicator for high skin doses.
The dose at the interventional reference point, IRP [19] , is available on some modern x-ray units. Skin dose at the IRP, estimated by the imaging system, is updated in real time but may overestimate the local skin dose as the patient may be positioned further away from the x-ray tube than the reference point. In addition, since x-ray beam projections are not stationary but vary in position and size on the patient's skin, the dose at the IRP may result in a further overestimation of the local skin dose. Rampado and Ropolo [20] developed a method to map the skin dose in interventional radiology in real time and estimated that the uncertainty in entrance skin dose is less than 20% (1SD, standard deviation). This is an important application since the spatial distribution of skin dose is only available with high resolution when radiographic films that require special calibration of their characteristic curves are used. Given the comparably small surface area of the head and the difficulty of fitting a radiographic film on its surface, it is feasible in interventional neuroradiology to place a number of small point dosimeters on the head in order to assess the spatial dose distribution [21] . This work enabled us to identify the locations on the head most likely to receive the highest doses and where we therefore placed dosimeters in this study.
According to Padovani and Quai [22] there are three reasons for dosimetry in interventional radiology: to estimate the risk of stochastic effects that apply mostly to young or middle-aged patients, quality assurance of the imaging equipment and to prevent the deterministic effects of the radiation that are the topic of this study. Risk is highest on the side where the x-rays first interact with the patient's skin, particularly if the beam projection is maintained in a stationary position and not resized. Patients at risk should be counselled and advised to check for skin changes 2-4 weeks after the procedure. Several papers present data on measured absorbed dose to patient skin following interventional neuroradiology [23] [24] [25] [26] or energy imparted to the patient [27] in order to correlate with acute and late radiation effects, respectively. In this paper, we report on measured local skin doses on the head of patients undergoing diagnostic or therapeutic neuroangiography using thermoluminescence dosimeters (TLDs) and compare these with the doses at the IRP as estimated by the x-ray unit in order to provide a method to determine the risk of local overexposure of skin and eye lenses.
Materials and methods

Interventional procedures, x-ray equipment and patients
The studies were performed on a biplanar angiography suite (Artis BA, Siemens AG, Erlangen, Germany). The x-ray unit has one floor-mounted (flo) and one ceilingmounted (cei) x-ray tube each with a 33-cm-diameter image intensifier. The floor-mounted x-ray tube is used in posterior-anterior views and the ceiling-mounted x-ray tube for lateral views. Each tube has an air kerma-area product (P KA ) meter mounted on the collimator (PTW Diamentor). The unit also presents a calculated dose at the IRP located along the central ray at a distance 150 mm from the isocentre towards the x-ray tube, at 600 mm from the focal spot. The dose at the IRP is displayed and updated continuously and used as an indicator of local maximum skin dose (D IRP ). As the unit has two x-ray tubes, the higher of the two doses D IRP,flo or D IRP,cei is denoted D IRP,max . The two x-ray tubes do not directly irradiate the same area of the head.
Cerebral digital subtraction angiography (DSA) was performed in the vascular territories of interest, which may include both internal carotid arteries, both external carotid arteries and the dominant or both vertebral arteries. For each vessel territory low magnification views in the angiographic anterior-posterior view and the lateral view were obtained initially and then magnified oblique views were obtained as necessary to depict the lesion or the anatomy. The routine film rate for each plane was 2 frames/s for the first 3 s (or 3 frames/s in the presence of a lesion that includes arteriovenous fistulas), and thereafter 1 frame/s for up to 10 s. The field-of-view (FOV) varies between 22 and 13 cm. The digital matrix was 1,024× 1,024 pixels. The distance from the focal spot to the patient's head varied usually between 500 and 600 mm, but was larger in the case of extremely angulated working projections. Rotational angiography was performed when necessary (usually for 3D depiction of aneurysms) with 200 frames over 210°.
Endovascular coiling of cerebral aneurysms included a complete DSA study, often including a rotational angiography series. Microcatheterization and coiling of the aneurysm were then performed using vascular road map at the best beam projections and maximum magnification (FOV=13 cm), and the projections were usually maintained stationary until the end of the procedure. Embolisation of cerebral arteriovenous malformation (AVM), arteriovenous fistulas (AVF) and hypervascular tumours included DSA studies and the procedures were performed using vascular road map and usually middle value of magnification (FOV=17 cm). These procedures often involved more than one microcatheterization and injection of embolics, and the beam projections were often resized. In all kinds of therapy, DSA runs were done when necessary during the procedures and always at the end of the procedures. A discussion of the devices and techniques for endovascular operations falls outside the scope of this article.
During the x-ray unit's period of operation (2004-2008), patient doses were recorded for 1,023 procedures, comprising 662 diagnostic angiographies; 226 treatments of cerebral aneurysms (endovascular coiling, in some instances with balloon-assisted technique or including stenting of the parent vessel) and 135 embolisations for cerebral AVMs and AVFs, or for preoperative embolisation of hypervascular tumours. Radiation doses during other endovascular operations (preoperative embolisation of tumours, pharmacologic or balloon angioplasty of vasospasm, and transarterial thrombolysis of ischaemic stroke) were recorded but are not included in this study.
Patient dosimetry
Since every intervention is unique and comprises many projections, including both fluoroscopy and digital fluorography, discrepancies between calculated values of D IRP and measured local absorbed doses on the skin are expected. To study this in 71 examinations including interventions (Fig. 1) , eight pairs of TLDs (Li 2 B 4 O 7 ) were positioned on the patient's head using a headband. Dosimeter read-out followed a standard protocol for the laboratory using a Rados Dosacus RE-1 reader, i.e. readout at 300°C; 1.5-s preheat, 8.5-s heating and pulse counting and 10-s post heating. The dosimeters were post annealed at 80°C for 1 h. The TLDs were calibrated to measure the superficial personal dose equivalent, H p (0.07) using the ISO/IEC N-40 spectrum. A selected number of dosimeters have been calibrated at the National Dosimetry Standard laboratory at the Swedish Radiation Safety Authority in Stockholm, where the dosimeters are calibrated for H p (10,α) and H p (0.07,α) on a ISO water slab phantom (300 mm×300 mm×150 mm, with 2.5-mmthick (polymethyl methacrylate, PMMA) walls at the front and 10-mm-thick walls elsewhere) [28] . The full set of dosimeters used in the study were calibrated individually at our laboratory by using a Rados Dosacus calibrator and the H p (0.07) response established by using the conversion factor between the Dosacus calibrator dosimeter response and the dosimeter response obtained in the ISO water slab phantom calibration. The quantity H p (0.07) was denoted either entrance skin dose ESD skin or ESD eye if the TLD represented the eye lens. The TLDs were positioned as follows: three dosimeters on the left side of the head, two on the back of the head, one on the right side and one on each eye to estimate the dose in the eye lens. The average dose of the two TLDs in the pair was used to represent the skin or eye lens dose at each position. The uncertainty in the calibration procedure was estimated to be less than 15% with a 95% confidence interval.
The measured maximum skin dose value (ESD skin,max ) was compared with the x-ray unit's estimation of the maximum skin dose (D IRP,max ) by calculating the conversion factor ESD skin,max /D IRP,max for each patient examination. In addition, conversion factors between ESD skin,max and the total P KA value were calculated in each examination. These data are useful for estimating maximum skin dose for situations where the x-ray units provide values of P KA but not of D IRP . The conversion factors, ESD skin,max /P KA for the skin dose and ESD eye,max /P KA for the eye dose, were compared in each examination. The average values of these conversion factors were then used to compute action levels in terms of the kerma-area product (P KA ) for exceeding the threshold doses needed to establish the effects; temporary epilation (3.0 Sv) [1] and lens cataract with visual impairment (1.5 Sv) [29] .
As a complement to the skin dose assessment, doses to the brain and other organs at risk in the proximity were investigated by dose measurements in an anthropomorphic female phantom (55 kg, 160 cm, Fig. 1) [30] . Twenty-two TLDs were inserted in the phantom to measure absorbed doses to the brain (D brain ) and nine TLDs in the salivary glands (D sg ) for simulated coiling and embolisations procedures, respectively. During the two simulations, the interventionist (SR) performed all the relevant fluoroscopy and digital subtraction angiography views typical of both the coiling and embolisation procedures, respectively. During these two sessions, the same type of headband with TLDs, worn by patients, was mounted on the anthropomorphic phantom. The fluoroscopy time, P KA value and doses at the IRP were recorded so that the mean organ doses in the phantom could be related to organ doses in the patients. These average doses were derived for future reference, since the uncertainty in the relative risk factors for developing late effects (cancer) after irradiation of the brain is high [29] .
Statistical analysis was performed using the software package Statistica (v. 6.0) and the Mann-Whitney U test. Table 2 shows the measured skin and eye doses from the smaller subset (n=71) of measurements using the TLDs. In addition, the P KA values and estimated values of D IRP were also recorded for this smaller subset and shown not to be significantly different (p>0.05) from the data given in Table 1 for the larger sample of all patients (n=1,023). Hence the large subset can be used to make predictions on estimated maximum doses to the skin and eye lens based on the P KA and D IRP data available for all patients.
Results
The interventional procedures result in significantly higher patient skin and eye doses than diagnostic angiography. The measured skin and eye dose distributions in coiling and embolisations were not statistically different. The highest doses are found on the back of the head or on the patient's left side. The doses to the patient's left and right eye are much lower than the skin doses; typically less than 5%, 9% and 14% of the maximum measured skin dose for angiography, coiling and embolisations procedures, respectively. The maximum eye dose of any of the patients measured was 515 mSv following a coiling procedure. The maximum measured skin doses were 2,950 mSv and 2,100 mSv in coiling and embolisation procedures, respectively, which are lower than the doses at the IRP estimated by the x-ray unit and given in Table 1 . Figure 2 shows the average and 95th percentile skin dose in each position for the three procedures. In all procedures, the highest dose is observed on the back right side of the head. The average and 95th percentile maximum measured skin doses per interventional (coiling vs. embolisation) procedure were 0.72 vs. 0.79 Sv and 1.7 vs. 1.9 Sv, respectively. The corresponding average and 95th percentile maximum absorbed doses to the patient's left eye were comparably lower with averages of 0.05 vs. 0.07 Sv and 0.14 vs. 0.20 Sv. In 85% of the cases, the absorbed dose to the patient's left eye was higher than to the right eye. Table 3 shows the ratio between the measured values of ESD skin,max and P KA and between the measured values of ESD eye,max and P KA for all three procedures. The ratio ESD eye,max /P KA for the dose to the eye lens is typically lower (average±1SD=0.38±0.64 mSv/Gy cm 2 ) than the corresponding factor ESD skin,max /P KA for the maximum measured skin dose (average±1SD=4.5±1.6 mSv/Gy cm 2 ). In some cases, the ratios are significantly larger than typical, indicating occasionally higher doses to the eye as shown by the 95% and maximum values in Table 3 . The numerical values above in parentheses are the average and standard deviations for all the 71 dose-measured procedures. The individual data for each type of procedure are given in Table 3 .
The higher of the average values between the measured maximum dose to the skin or eye lens and the total P KA were in the two interventional procedures 4.9 mSv/Gy cm 2 (skin, coiling) and 0.58 mSv/Gy cm 2 (eye lens, embolisation), respectively (Table 3) . Corresponding action levels of the kerma-area product for temporary epilation or lens cataract are therefore 612 Gy cm 2 (skin) and 2,586 Gy cm 2 (eye lens), respectively, indicating that here the skin is the limiting organ and not the eye lens. Table 3 also shows the ratios between the maximum skin doses measured by TLDs for each procedure and the maximum doses as estimated by either of the two x-ray tubes in the interventional reference point (IRP): ESD skin,max /D IRP,max . The ratio is in all cases less than 1 (average±1SD=0.44±0.18 mSv/mGy) but shows large variations, indicating poor agreement but reasonable positive correlation between the two (r 2 =0.77). The measured maximum skin dose (ESD skin,max ) is thus significantly lower than the estimated dose at the IRP indicating that D IRP,max overestimates the skin dose by approximately a factor of 2. Given the data in Tables 1 and  2 , the risk of temporary skin epilation (ESD>3 Sv) is not as high as initially assumed from the values of D IRP,max displayed by the x-ray unit. Table 4 shows the organ dose relative to the kerma-area product (P KA ) when the two interventional procedures were simulated on an anthropomorphic phantom. Assessing each interventional procedure individually, the average brain doses are estimated to be 250 mSv and 340 mSv and the salivary gland doses 60 mSv and 110 mSv for the coiling and embolisation procedures, respectively.
Discussion
Based on the average conversion factor between measured skin dose and P KA 4.9 mSv/Gy cm 2 from Table 3 , the computed action level for temporary epilation from this work was 612 Gy cm 2 . Since 2004, when operations started at our hospital, such a high P KA value has only been observed in three embolisation procedures. These three patients were subject to averages of 88 min of fluoroscopy, P KA 640 Gy cm 2 and D IRP 5.5 Gy. The corresponding maximum values are 143 min, 676 Gy cm 2 and 7.2 Gy. However, none of these patients were among those 71 measured by the TLDs. To our knowledge, during the study period 2004-2008, only one patient experienced erythema and temporary epilation following the coiling of an aneurysm, indicating that our suggested action level is appropriate for our purposes.
In order to obtain representative skin dose mapping with a limited number of TLDs, the number of TLDs used and their precise position is important. Nishizawa et al. [21] measured the surface dose on two patients' heads with 27 photoluminescent glass dosimeters positioned evenly over the whole surface of the head and neck. After embolisation treatment of the patients' small aneurysms, the maximum skin dose was located on the back of the head behind the right ear. Moritake et al. [31] extended the study to 32 patients and found maximum skin dose on the back of the head at the level of the ears. Hence, we conclude that the position of maximum skin dose in their study agrees with the positions of our TLDs on our 71 patients.
As obtained by Chida et al. [12] for PCI, we also found a correlation between maximum skin dose (ESD skin,max ) and kerma-area product (P KA ) in all three examinations (r 2 = 0.94, 0.74 and 0.85 in angiography, coiling and embolisation, respectively), but poorer correlation with fluoroscopy time (r 2 =0.09, 0.57 and 0.57, respectively). A reason for the more significant correlation between ESD skin,max and P KA in our work compared with, for example, Balter et al.'s [17] , may be that in our work the large majority of the procedures were performed by one very experienced radiologist. We therefore agree with Balter and Moses [9] who proposed that both ESD and P KA could be used as key dosimetric quantities to avoid patient overexposure.
Vano et al. [16] found third quartile values of P KA and fluoroscopy time for the diagnostic procedure cerebral angiography of 107 Gy cm 2 and 12 min. They also suggest preliminary reference levels for this procedure of 120 Gy cm 2 and 15 min based also on the other five references quoted in their publication. Our corresponding data are 72 Gy cm 2 and 7.5 min, i.e. 50-60% of the preliminary reference level.
Persliden [32] Table 2 are much lower. However, the ratio between the dose in the lateral and the frontal views in the diagnostic procedure is the same as in our study, approximately 0.5. Mooney et al. [6] estimated the maximum skin dose in embolisations (AVM) to be 5 Sv, once again higher than those found here. Bergeron et al. [24] measured the maximum entrance skin dose in neurovascular interventions to be between 0.13 and 1.3 Sv, whereas our measurements suggest that skin doses as high as 3.0 Sv can be found. Kuwayama et al. [26] measured the dose to the patient during 15 endovascular treatments (AVM and AVF). The dose to the dosimeter at the glabella corresponds approximately to those in our dosimeters placed on the patients' left and right eyes. Their eye doses are within the range 3-136 mSv, which is in reasonable agreement with our doses of 10-289 mSv in embolisation procedures.
There are many reasons for the dose at the interventional reference point (IRP) to overestimate the skin doses. During the procedure, the beam direction and projection are altered and the beam is not always centred exactly on the same area of the skin. In addition, the patient's skin may be located further away from the x-ray tube than the IRP, because the distance between the isocentre (the point of interest) and the patient surface close to the x-ray tube is less than 150 mm. According to the radiologist, the probability of any given skin area being directly irradiated from both x-ray tubes is very low.
The left eye typically absorbed a higher dose than the right eye. This is mainly because the x-ray tube that generates the lateral view is located on the left side of the patient.
Conclusions
The 95th percentile of the maximum local skin dose was 1.7-1.9 Sv, but the corresponding doses to the eye lens were significantly lower, being 0.14-0.20 Sv for coiling and embolisation procedures. The average conversion factor between measured skin dose and P KA was 4.5± 1.6 mSv/Gy cm 2 in interventional neuroradiology. The dose at the interventional reference point estimated by the x-ray unit overestimates the local skin dose by approximately a factor of 2 but with a large variation. Based on the local skin doses observed here there is no immediate risk of temporary epilation (ESD>3 Sv) for patients in our hospital. For the two interventional procedures, the risk of induction of cataract with visual impairment is not as high as initially expected from the dose at the interventional Table 3 Average, median, 95th percentile and maximum values of the ratio ESD skin,max /P KA , ESD eye,max /P KA and the ratio between the maximum measured skin doses (ESD skin,max ) and the maximum doses at the interventional reference point (D IRP,max ) for the three procedures reference point. Establishing action levels in terms of kerma-area products or dose at the interventional reference point on each procedure and x-ray unit will facilitate identification of individual patients at risk.
